Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1294920.RAovR4IpR5u9IftbiXtoW48AdHKHP2CcpDqM29UBpdefk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1294920.RAovR4IpR5u9IftbiXtoW48AdHKHP2CcpDqM29UBpdefk130_assertion type Assertion NP1294920.RAovR4IpR5u9IftbiXtoW48AdHKHP2CcpDqM29UBpdefk130_head.
- NP1294920.RAovR4IpR5u9IftbiXtoW48AdHKHP2CcpDqM29UBpdefk130_assertion description "[The results suggest using Rho-kinase inhibitors to reactivate the p53-PIG3 axis as a novel therapeutic strategy; we suggest that the use of antioxidants in melanoma should be very carefully evaluated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294920.RAovR4IpR5u9IftbiXtoW48AdHKHP2CcpDqM29UBpdefk130_provenance.
- NP1294920.RAovR4IpR5u9IftbiXtoW48AdHKHP2CcpDqM29UBpdefk130_assertion evidence source_evidence_literature NP1294920.RAovR4IpR5u9IftbiXtoW48AdHKHP2CcpDqM29UBpdefk130_provenance.
- NP1294920.RAovR4IpR5u9IftbiXtoW48AdHKHP2CcpDqM29UBpdefk130_assertion SIO_000772 26464464 NP1294920.RAovR4IpR5u9IftbiXtoW48AdHKHP2CcpDqM29UBpdefk130_provenance.
- NP1294920.RAovR4IpR5u9IftbiXtoW48AdHKHP2CcpDqM29UBpdefk130_assertion wasDerivedFrom befree-2016 NP1294920.RAovR4IpR5u9IftbiXtoW48AdHKHP2CcpDqM29UBpdefk130_provenance.
- NP1294920.RAovR4IpR5u9IftbiXtoW48AdHKHP2CcpDqM29UBpdefk130_assertion wasGeneratedBy ECO_0000203 NP1294920.RAovR4IpR5u9IftbiXtoW48AdHKHP2CcpDqM29UBpdefk130_provenance.